Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 24.34
(1.29%)
INR 24.34
(1.29%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 14.22 Million INR | -96.08% |
| 2021 | 362.49 Million INR | 168.71% |
| 2020 | 134.9 Million INR | -73.92% |
| 2019 | 517.18 Million INR | 258.18% |
| 2018 | 144.39 Million INR | 738.71% |
| 2017 | 17.21 Million INR | 363.42% |
| 2016 | 3.71 Million INR | -98.35% |
| 2015 | 224.74 Million INR | -12.36% |
| 2014 | 256.45 Million INR | -14.19% |
| 2013 | 298.87 Million INR | -6.84% |
| 2012 | 320.81 Million INR | 62.09% |
| 2011 | 197.92 Million INR | 1232.66% |
| 2010 | 14.85 Million INR | -29.73% |
| 2009 | 21.13 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 14.24 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 14.22 Million INR | -96.08% |
| 2022 Q4 | 14.22 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 82.31 Million INR | 0.0% |
| 2021 Q4 | 362.49 Million INR | -35.81% |
| 2021 Q2 | 248.34 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | 564.75 Million INR | 127.4% |
| 2021 FY | 362.49 Million INR | 168.71% |
| 2020 Q2 | 330.26 Million INR | 0.0% |
| 2020 Q4 | 134.9 Million INR | -42.36% |
| 2020 FY | 134.9 Million INR | -73.92% |
| 2020 Q3 | 234.05 Million INR | -29.13% |
| 2019 Q2 | 459.7 Million INR | 0.0% |
| 2019 Q4 | 517.18 Million INR | 0.0% |
| 2019 FY | 517.18 Million INR | 258.18% |
| 2018 Q2 | 166.68 Million INR | 0.0% |
| 2018 Q4 | 144.39 Million INR | 0.0% |
| 2018 FY | 144.39 Million INR | 738.71% |
| 2017 FY | 17.21 Million INR | 363.42% |
| 2017 Q4 | 17.21 Million INR | 0.0% |
| 2017 Q2 | 64.4 Million INR | 0.0% |
| 2016 Q2 | 499.66 Million INR | 0.0% |
| 2016 Q4 | 3.71 Million INR | 0.0% |
| 2016 FY | 3.71 Million INR | -98.35% |
| 2015 Q2 | 351.39 Million INR | 0.0% |
| 2015 Q4 | 224.74 Million INR | 0.0% |
| 2015 FY | 224.74 Million INR | -12.36% |
| 2014 Q4 | 256.45 Million INR | 0.0% |
| 2014 FY | 256.45 Million INR | -14.19% |
| 2013 Q4 | 298.87 Million INR | 0.0% |
| 2013 FY | 298.87 Million INR | -6.84% |
| 2012 FY | 320.81 Million INR | 62.09% |
| 2012 Q4 | 320.81 Million INR | 0.0% |
| 2011 FY | 197.92 Million INR | 1232.66% |
| 2011 Q4 | 197.92 Million INR | 0.0% |
| 2010 FY | 14.85 Million INR | -29.73% |
| 2009 FY | 21.13 Million INR | 0.0% |
| 2009 Q4 | 21.13 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sunil Healthcare Limited | 140.54 Million INR | 89.881% |
| ANG Lifesciences India Limited | 477.65 Million INR | 97.023% |
| BDH Industries Limited | 50.02 Million INR | 71.57% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 33.26 Million INR | 57.253% |
| Jenburkt Pharmaceuticals Limited | 85.61 Million INR | 83.39% |
| Patidar Buildcon Limited | 12.6 Million INR | -12.82% |
| Add-Shop E-Retail Limited | 257.94 Million INR | 94.487% |
| Cian Healthcare Limited | 409.27 Million INR | 96.525% |
| Concord Drugs Limited | 229.23 Million INR | 93.796% |
| Gujarat Terce Laboratories Limited | 39.84 Million INR | 64.313% |
| Sastasundar Ventures Limited | 1.15 Billion INR | 98.772% |
| Source Natural Foods and Herbal Supplements Limited | 43.01 Million INR | 66.936% |
| Syschem (India) Limited | 513.95 Million INR | 97.233% |
| Medi-Caps Limited | 57.35 Million INR | 75.207% |
| Parmax Pharma Limited | 43.06 Million INR | 66.975% |
| Smruthi Organics Limited | 297.76 Million INR | 95.224% |
| Phaarmasia Limited | 85 Million INR | 83.27% |
| Tyche Industries Limited | 125.56 Million INR | 88.674% |
| Zenith Healthcare Limited | 19.76 Million INR | 28.057% |
| Denis Chem Lab Limited | 101.89 Million INR | 86.044% |
| Kwality Pharmaceuticals Limited | 783.87 Million INR | 98.186% |
| Panchsheel Organics Limited | 395.22 Million INR | 96.402% |
| Vivanza Biosciences Limited | 20.06 Million INR | 29.118% |
| Bacil Pharma Limited | -45.66 Thousand INR | 31245.423% |
| Beryl Drugs Limited | 12.6 Million INR | -12.847% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 8.46 Million INR | -67.918% |
| Deccan Health Care Limited | 456.96 Million INR | 96.888% |
| Hindustan Bio Sciences Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | 10.64 Million INR | -33.631% |
| KIMIA BIOSCIENCES LIMITED | 308.03 Million INR | 95.383% |
| Makers Laboratories Limited | 338.04 Million INR | 95.793% |
| MedPlus Health Services Limited | 13.4 Billion INR | 99.894% |
| Mercury Laboratories Limited | 62.06 Million INR | 77.087% |
| Parnax Lab Limited | 299.27 Million INR | 95.248% |
| PRAVEG LIMITED | 120.99 Million INR | 88.246% |
| Sanjivani Paranteral Limited. | 97.33 Million INR | 85.389% |
| SHAMROCK INDUSTRIAL CO.LTD. | -7.1 Million INR | 300.07% |
| SUDARSHAN PHARMA INDUSTRIES LI | 857.41 Million INR | 98.341% |
| Trident Lifeline Limited | 125.84 Million INR | 88.699% |
| Transchem Limited | 1.00 INR | -1422099900.0% |
| Trinity League India Limited | 24.76 Million INR | 42.579% |
| Vikram Thermo (India) Limited | 146.62 Million INR | 90.301% |
| Vista Pharmaceuticals Limited | 67.86 Million INR | 79.044% |
| Zenlabs Ethica Limited | 119.95 Million INR | 88.144% |
| SHELTER PHARMA LIMITED | 99.29 Million INR | 85.677% |
| Vasundhara Rasayans Limited | 17.34 Million INR | 17.997% |
| Roopa Industries Limited | 251.62 Million INR | 94.348% |
| PANJON LTD. | 37.42 Million INR | 61.996% |
| Pharmaids Pharmaceuticals Limited | 35.91 Million INR | 60.403% |
| TIAAN CONSUMER LIMITED | 37.1 Million INR | 61.672% |
| Anuh Pharma Limited | 754 Million INR | 98.114% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 891 Thousand INR | -1496.072% |
| Sandu Pharmaceuticals Limited | 122.5 Million INR | 88.392% |
| Fredun Pharmaceuticals Limited | 1.78 Billion INR | 99.203% |
| Trimurthi Limited | 11.94 Million INR | -19.059% |
| Shukra Pharmaceuticals Limited | 23.14 Million INR | 38.554% |
| Norris Medicines Limited | 43.33 Million INR | 67.184% |
| Veerhealth Care Limited | 13.96 Million INR | -1.87% |
| Lactose (India) Limited | 167.93 Million INR | 91.532% |
| OXYGENTA PHARMACEUTICAL LIMITE | 137.16 Million INR | 89.632% |
| Ambalal Sarabhai Enterprises Limited | 161.76 Million INR | 91.209% |
| Gennex Laboratories Limited | 251.75 Million INR | 94.351% |
| Godavari Drugs Limited | 206.5 Million INR | 93.113% |
| Zenotech Laboratories Limited | 8.4 Million INR | -69.257% |
| Shree Ganesh Remedies Limited | 249.88 Million INR | 94.309% |
| Bharat Parenterals Limited | 614.67 Million INR | 97.686% |
| Coral Laboratories Limited | 151.56 Million INR | 90.617% |
| Evoq Remedies Limited | 31.25 Million INR | 54.493% |
| Kerala Ayurveda Limited | 155 Million INR | 90.825% |
| KOBO BIOTECH LIMITED | 180.4 Million INR | 92.117% |
| Natural Capsules Limited | 190.35 Million INR | 92.529% |
| Auro Laboratories Limited | 82.39 Million INR | 82.741% |